[1] JULIA N. HEINRICH . Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists[J]. European journal of pharmacology, 2009, 605 1: Pages 53-56. DOI:
10.1016/j.ejphar.2008.12.044[2] De Souza, F.I., Zumiotti, A.V., and Da Silva, C.F. Neuregulins 1-α and 1-β on the regeneration the peripheral nerves[J]. Acta Ortop Bras.
[3] MAIBRITT B ANDERSEN. The Muscarinic M1/M4 Receptor Agonist Xanomeline Exhibits Antipsychotic-Like Activity in Cebus apella Monkeys[J]. Neuropsychopharmacology, 2003, 28 6: 1168-1175. DOI:
10.1038/sj.npp.1300151[4] MESSER W S. The utility of muscarinic agonists in the treatment of alzheimer’s disease[J]. Journal of Molecular Neuroscience, 2002, 19 1-2: 187-193. DOI:
10.1007/s12031-002-0031-5